Search

everythinglearnresearchcommunity

for

Search:↓

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document covers various male health issues, their causes, treatments, and related conditions.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Skin symptoms can indicate endocrine disorders and have various treatments.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.